2 Result: AVROBIO
Ault Alliance Soars On Financial Status; AVROBIO Climbs On Strategic Leap
July 12th, 2023
Shares of Ault Alliance, Inc. (NYSE American: AULT) surged over 100% in pre-market trading after the company provided a business update highlighting its financial status. With approximately 2.1 million shares outstanding and a book value of around. Read more
AVROBIO Sells Cystinosis Therapy Program to Novartis, Stock Surges; Compass Minerals Inks Lithium Supply Deal with Ford; Global-e Online Beats Estimates, Stock Declines
May 22nd, 2023
AVROBIO, Inc. (Nasdaq: AVRO) has made a significant announcement, revealing that it has entered into an agreement to sell its investigational hematopoietic stem cell (HSC) gene therapy program for the treatment of cystinosis to Novartis (NYSE: NVS). . Read more
Want To Find Some News?
News By Industries
Recent Post
-
Earnings Preview: Walt Disney, Applied Materials, and Celcuity Take Center Stage
November 11th, 2024Key Metrics: CyberArk Software, Hudbay Minerals, and Sonos Earnings Due
November 11th, 2024Earnings: What to Expect from Occidental Petroleum, Rocket Lab, and CAE
November 10th, 2024Earnings Countdown: Home Depot, Sea Limited, and Natera in the Spotlight
November 10th, 2024Ahead of Earnings: DoorDash, MetLife, and Exelon in the Spotlight
October 27th, 2024
Member Login